Here, the combination of AP2α ablation and SAHA administration gave a similar robust and significant increase in RAI uptake in thyroid cancer cells compared to each treatment alone (Fig. 5A), indicating that inhibiting endocytosis enhances the impact of SAHA on NIS function. The gene discussed is SLC5A5; the disease is thyroid cancer.